Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep950 | Thyroid (non-cancer) | ECE2015

Radioiodine treatment of Graves' disease: dose–response analysis

Cepkova Jitka , Svilias Ioannis , Krcalova Eva , Horacek Jiri

Introduction: Despite more than 60 yearsÂ’ experience with radioactive iodine 131I (RAI) treatment of GravesÂ’ disease (GD) about the most appropriate dosing regime is still controversial. The objective of our research was to analyse the outcome of RAI therapy in our cohort of patients.Methods: Retrospectively, we analysed 603 patients with GD (500 women and 103 men, mean age 51.5±12.7 years) treated with RAI. According to recomme...

ea0070aep929 | Thyroid | ECE2020

No important salivary gland damage following radioiodine remnant ablation

Krcalova Eva , Horacek Jiri , Gabalec Filip , Zak Pavel , Dolezal Jiri

Radioiodine (131I, RAI) has traditionally been used in thyroid cancer treatment but its benefitshould be balanced against possible risks. Among them, salivary gland dysfunction has oftenbeen discussed, although the reported data have been inconsistent. While some authors reported functional changes following higher (mostly cumulative) activities, there have been scarce data on the activity of 3.7 GBq (100 mCi) that is most commonly used for RAI remnant ablation...

ea0056ep20 | Adrenal and Neuroendocrine Tumours | ECE2018

Malignant sympathetic paraganglioma – case report

Svilias Ioannis , Zelinka Tomas , Krcalova Eva , Cap Jan

Introduction: Paragangliomas are rare neuroendocrine tumors that arise from the extraadrenal paraganglia. Sympathetic paragangliomas usually secrete catecholamines and are located in the sympathetic paravertebral ganglia of thorax, abdomen and pelvis.Case report: We present a 66 year old patient with an incidentally found retroperitoneal mass on spine MRI. An open biopsy was performed (9/15) with the histological finding of benign paraganglioma (accordin...